The potential role of iron and copper in pediatric obesity and nonalcoholic fatty liver disease

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Feldman, Alexandra ^a   Aigner, Elmar ^a   Weghuber, Daniel ^a   Paulmichl, Katharina ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; FERRITIN; HEPCIDIN; IRON;

CHILDHOOD OBESITY; COPPER DEFICIENCY; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON INTAKE; IRON METABOLISM; IRON TRANSPORT; NEGATIVE FEEDBACK; NONALCOHOLIC FATTY LIVER; REVIEW; ANIMAL; INFLAMMATION; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; COPPER; HUMANS; INFLAMMATION; IRON; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PEDIATRIC OBESITY;

EID: 84939178806     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/287401     Document Type: Review

References (77)

1. K. E. Corey and L. M. Kaplan, "Obesity and liver disease: the epidemic of the twenty-first century," Clinics in Liver Disease, vol. 18, no. 1, pp. 1-18, 2014.
2. J. B. Schwimmer, R. Deutsch, T. Kahen, J. E. Lavine, C. Stanley, and C. Behling, "Prevalence of fatty liver in children and adolescents," Pediatrics, vol. 118, no. 4, pp. 1388-1393, 2006.
3. A. E. Feldstein, P. Charatcharoenwitthaya, S. Treeprasertsuk, J. T. Benson, F. B. Enders, and P. Angulo, "The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years," Gut, vol. 58, no. 11, pp. 1538-1544, 2009.
4. J. B. Schwimmer, C. Behling, R. Newbury et al. , "Histopathology of pediatric nonalcoholic fatty liver disease," Hepatology, vol. 42, no. 3, pp. 641-649, 2005.
5. P. Vajro, S. Lenta, P. Socha et al. , "Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN hepatology committee," Journal of Pediatric Gastroenterology and Nutrition, vol. 54, no. 5, pp. 700-713, 2012.
6. P. Jacobs and C. A. Finch, "Iron for erythropoiesis," Blood, vol. 37, no. 2, pp. 220-230, 1971.
7. L. Hallberg, "Bioavailability of dietary iron in man," Annual Review of Nutrition, vol. 1, pp. 123-147, 1981.
8. M. P. Mims and J. T. Prchal, "Divalent metal transporter 1," Hematology, vol. 10, no. 4, pp. 339-345, 2005.
9. T. Ganz, "Cellular iron: ferroportin is the only way out," Cell Metabolism, vol. 1, no. 3, pp. 155-157, 2005.
10. T. Korolnek and I. Hamza, "Like iron in the blood of the people: the requirement for heme trafficking in ironmetabolism," Drug Metabolism and Transport, vol. 5, article 126, 2014.
11. P. Ponka, C. Beaumont, and D. R. Richardson, "Function and regulation of transferrin and ferritin," Seminars in Hematology, vol. 35, no. 1, pp. 35-54, 1998.
12. J. Petrak and D. Vyoral, "Hephaestin-a ferroxidase of cellular iron export," International Journal of Biochemistry and Cell Biology, vol. 37, no. 6, pp. 1173-1178, 2005.
13. R. Newman, C. Schneider, R. Sutherland , L. Vodinelich, and M. Greaves, "The transferrin receptor," Trends in Biochemical Sciences, vol. 7, no. 11, pp. 397-400, 1982.
14. Y. Kohgo, K. Ikuta, T. Ohtake, Y. Torimoto, and J. Kato, "Body iron metabolism and pathophysiology of iron overload," International Journal of Hematology, vol. 88, no. 1, pp. 7-15, 2008.
15. T. Ganz, "Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation," Blood, vol. 102, no. 3, pp. 783-788, 2003.
16. E. Nemeth, M. S. Tuttle, J. Powelson et al. , "Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization," Science, vol. 306, no. 5704, pp. 2090-2093, 2004.
17. S. Bekri, P. Gual, R. Anty et al. , "Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH," Gastroenterology, vol. 131, no. 3, pp. 788-796, 2006.
18. H. Kulaksiz, E. Fein, P. Redecker, W. Stremmel, G. Adler, and Y. Cetin, "Pancreatic beta-cells express hepcidin, an iron-uptake regulatory peptide," Journal of Endocrinology, vol. 197, no. 2, pp. 241-249, 2008.
19. P. L. Lee and E. Beutler, "Regulation of hepcidin and ironoverload disease," Annual Review of Pathology: Mechanisms of Disease, vol. 4, no. 1, pp. 489-515, 2009.
20. B. Chung, P. Matak, A. T. McKie, and P. Sharp, "Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells," Journal of Nutrition, vol. 137, no. 11, pp. 2366-2370, 2007.
21. E. Nemeth, S. Rivera, V. Gabayan et al. , "IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin," The Journal of Clinical Investigation, vol. 113, no. 9, pp. 1271-1276, 2004.
22. S. G. Gehrke, H. Kulaksiz, T. Herrmann et al. , "Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron," Blood, vol. 102, no. 1, pp. 371-376, 2003.
23. M. Nairz, D. Haschka, E. Demetz, and G. Weiss, "Iron at the interface of immunity and infection," Frontiers in Pharmacology, vol. 5, article 152, 2014.
24. I. Aeberli, M. Kaspar, and M. B. Zimmermann, "Dietary intake and physical activity of normal weight and overweight 6-to 14-year-old Swiss children," Swiss Medical Weekly, vol. 137, no. 29-30, pp. 424-430, 2007.
25. G. Moschonis, G. P. Chrousos, C. Lionis, V. Mougios, Y. Manios, and Healthy Growth Study Group, "Association of total bodyand visceral fatmass with iron deficiency in preadolescents: the Healthy Growth Study," British Journal of Nutrition, vol. 108, no. 4, pp. 710-719, 2012.
26. K. G. Nead, J. S. Halterman, J. M. Kaczorowski, P. Auinger, and M. Weitzman, "Overweight children and adolescents: a risk group for iron deficiency," Pediatrics, vol. 114, no. 1, pp. 104-108, 2004.
27. A. C. Cepeda-Lopez, S. J. M. Osendarp, A. Melse-Boonstra et al. , "Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake," The American Journal of Clinical Nutrition, vol. 93, no. 5, pp. 975-983, 2011.
28. O. Pinhas-Hamiel, R. S. Newfield, I. Koren, A. Agmon, P. Lilos, and M. Phillip, "Greater prevalence of iron deficiency in overweight and obese children and adolescents," International Journal of Obesity, vol. 27, no. 3, pp. 416-418, 2003.
29. M. H. Eftekhari, H. Mozaffari-Khosravi, and F. Shidfar, "The relationship between BMI and iron status in iron-deficient adolescent Iranian girls," Public Health Nutrition, vol. 12, no. 12, pp. 2377-2381, 2009.
30. M. Ferrari, L. Mistura, E. Patterson et al. , "Evaluation of iron status in European adolescents through biochemical iron indicators: the HELENA Study," European Journal of Clinical Nutrition, vol. 65, no. 3, pp. 340-349, 2011.
31. J. Baumgartner, C. M. Smuts, I. Aeberli, L. Malan, H. Tjalsma, and M. B. Zimmermann, "Overweight impairs efficacy of iron supplementation in iron-deficient South African children: a randomized controlled intervention," International Journal of Obesity, vol. 37, no. 1, pp. 24-30, 2013.
32. A. Amato, N. Santoro, P. Calabrò et al. , "Effect of body mass index reduction on serum hepcidin levels and iron status in obese children," International Journal of Obesity, vol. 34, no. 12, pp. 1772-1774, 2010.
33. L. Gong, F. Yuan, J. Teng et al. , "Weight loss, inflammatory markers, and improvements of iron status in overweight and obese children," Journal of Pediatrics, vol. 164, no. 4, pp. 795. e2-800. e2, 2014.
34. I. Aeberli, R. F. Hurrell, and M. B. Zimmermann, "Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children," International Journal of Obesity, vol. 33, no. 10, pp. 1111-1117, 2009.
35. M. F. Mujica-Coopman, A. Brito, D. López de Romaña, F. Pizarro, and M. Olivares, "Body mass index, iron absorption and iron status in childbearing age women," Journal of Trace Elements in Medicine and Biology, 2014.
36. E. M. del Giudice, N. Santoro, A. Amato et al. , "Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency," The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 12, pp. 5102-5107, 2009.
37. M. V. V. Falzacappa, M. V. Spasic, R. Kessler, J. Stolte, M. W. Hentze, and M. U. Muckenthaler, "STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation, " Blood, vol. 109, no. 1, pp. 353-358, 2007.
38. L. Tussing-Humphreys, K. N. Frayn, S. R. Smith et al. , "Subcutaneous adipose tissue fromobese and leanadults does not release hepcidin in vivo," TheScientificWorldJournal, vol. 11, pp. 2197-2206, 2011.
39. T. Ganz and E. Nemeth, "Iron sequestration and anemia of inflammation," Seminars in Hematology, vol. 46, no. 4, pp. 387-393, 2009.
40. M. Manco, A. Alisi, J.-M. F. Real et al. , "Early interplay of intra-hepatic iron and insulin resistance in children with nonalcoholic fatty liver disease," Journal of Hepatology, vol. 55, no. 3, pp. 647-653, 2011.
41. F. Demircioʇlu, G. Görńmez, E. Daʇistan et al. , "Serum hepcidin levels and ironmetabolism in obese children with and without fatty liver: case-control study," European Journal of Pediatrics, vol. 173, no. 7, pp. 947-951, 2014.
42. A. Piperno, "Classification and diagnosis of Iron overload," Haematologica, vol. 83, no. 5, pp. 447-455, 1998.
43. E. Aigner, A. Feldman, and C. Datz, "Obesity as an emerging risk factor for iron deficiency," Nutrients, vol. 6, no. 9, pp. 3587-3600, 2014.
44. L. Valenti, A. L. Fracanzani, E. Bugianesi et al. , "HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease," Gastroenterology, vol. 138, no. 3, pp. 905-912, 2010.
45. E. Aigner, C. Hinz, K. Steiner et al. , "Iron stores, liver transaminase levels and metabolic risk in healthy teenagers," European Journal of Clinical Investigation, vol. 40, no. 2, pp. 155-163, 2010.
46. T. C. H. Tan, D. H. G. Crawford, L. A. Jaskowski et al. , "Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury," Laboratory Investigation, vol. 93, no. 12, pp. 1295-1312, 2013.
47. B. van deWier, J. M. Balk, G. R. M. M. Haenen et al. , "Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production," FEBS Letters, vol. 587, no. 15, pp. 2461-2466, 2013.
48. D. Moya, S. S. Baker, W. Liu et al. , "Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis (1042. 1)," The FASEB Journal, vol. 28, no. 1, supplement, p. 1042. 1, 2014.
49. E. M. Brunt, "Pathology of nonalcoholic fatty liver disease," Nature Reviews Gastroenterology and Hepatology, vol. 7, no. 4, pp. 195-203, 2010.
50. P. Tessari, A. Coracina, A. Cosma, and A. Tiengo, "Hepatic lipid metabolism and non-alcoholic fatty liver disease," Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 4, pp. 291-302, 2009.
51. B. Halliwell and J. M. C. Gutteridge, "Oxygen toxicity, oxygen radicals, transition metals and disease," Biochemical Journal, vol. 219, no. 1, pp. 1-14, 1984.
52. B. Halliwell and J. M. C. Gutteridge, "Role of free radicals and catalytic metal ions in human disease: an overview," Methods in Enzymology, vol. 186, pp. 1-85, 1990.
53. P. Sorrentino, S. DAngelo, U. Ferbo, P. Micheli, A. Bracigliano, and R. Vecchione, "Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis," Journal of Hepatology, vol. 50, no. 2, pp. 351-357, 2009.
54. C. Datz, T. K. Felder, D. Niederseer, and E. Aigner, "Iron homeostasis in the metabolic syndrome," European Journal of Clinical Investigation, vol. 43, no. 2, pp. 215-224, 2013.
55. T. J. Weismüller, G. I. Kirchner, M. N. Scherer et al. , "Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-termrecipient survival," Hepatology (Baltimore, Md), vol. 54, no. 6, pp. 2114-2124, 2011.
56. N. M. Walker, K. A. Stuart, R. J. Ryan et al. , "Serum ferritin concentration predicts mortality in patients awaiting liver transplantation," Hepatology, vol. 51, no. 5, pp. 1683-1691, 2010.
57. I. Scheiber, R. Dringen, and J. F. B. Mercer, "Copper: effects of deficiency and overload," in Interrelations between Essential Metal Ions and Human Diseases, A. Sigel, H. Sigel, and R. K. O. Sigel, Eds. , vol. 13 of Metal Ions in Life Sciences, pp. 359-387, Springer, DeLeon Springs, Fla, USA, 2013.
58. A. A. Al-Othman, F. Rosenstein, and K. Y. Lei, "Copper deficiency alters plasma pool size, percent composition and concentration of lipoprotein components in rats," Journal of Nutrition, vol. 122, no. 6, pp. 1199-1204, 1992.
59. E. Aigner, M. Strasser, H. Haufe et al. , "A role for low hepatic copper concentrations in nonalcoholic fatty liver disease," The American Journal of Gastroenterology, vol. 105, no. 9, pp. 1978-1985, 2010.
60. L. M. Klevay, "Is theWestern diet adequate in copper?" Journal of Trace Elements in Medicine and Biology, vol. 25, no. 4, pp. 204-212, 2011.
61. A. A. Al-Othman, F. Rosenstein, and K. Y. Lei, "Copper deficiency increases in vivo hepatic synthesis of fatty acids, triacylglycerols, and phospholipids in rats," Proceedings of the Society for Experimental Biology and Medicine, vol. 204, no. 1, pp. 97-103, 1993.
62. J. R. Prohaska, J. Geissler, B. Brokate, and M. Broderius, "Copper, zinc-superoxide dismutase protein but not mRNA is lower in copper-deficient mice and mice lacking the copper chaperone for superoxide dismutase," Experimental Biology and Medicine, vol. 228, no. 8, pp. 959-966, 2003.
63. D. A. Schuschke, A. S. O. Adeagbo, P. K. Patibandla, U. Egbuhuzo, R. Fernandez-Botran, and W. T. Johnson, "Cyclooxygenase-2 is upregulated in copper-deficient rats," Inflammation, vol. 32, no. 5, pp. 333-339, 2009.
64. Y. Wei, R. S. Rector, J. P. Thyfault, and J. A. Ibdah, "Nonalcoholic fatty liver disease and mitochondrial dysfunction," World Journal of Gastroenterology, vol. 14, no. 2, pp. 193-199, 2008.
65. Y. Cayir, A. Cayir, M. I. Turan et al. , "Antioxidant status in blood of obese children: the relation between trace elements, paraoxonase, and arylesterase values," Biological Trace Element Research, vol. 160, no. 2, pp. 155-160, 2014.
66. S. F. A. Azab, S. H. Saleh, W. F. Elsaeed, M. A. Elshafie, L. M. Sherief, and A. M. H. Esh, "Serumtrace elements in obese Egyptian children: a case-control study," Italian Journal of Pediatrics, vol. 40, no. 1, article 20, 2014.
67. M. E. Tascilar, I. T. Ozgen, A. Abaci, M. Serdar, and O. Aykut, "Trace elements in obese Turkish children," Biological Trace Element Research, vol. 143, no. 1, pp. 188-195, 2011.
68. J. Suliburska, S. Cofta, E. Gajewska et al. , "The evaluation of selected serum mineral concentrations and their association with insulin resistance in obese adolescents," European Review for Medical and Pharmacological Sciences, vol. 17, no. 17, pp. 2396-2400, 2013.
69. S. C. V. C. Lima, R. F. Arrais, C. H. Sales et al., "Assessment of copper and lipid profile in obese children and adolescents, " Biological Trace Element Research, vol. 114, no. 13, pp. 19-30, 2006.
70. R. Laitinen, E. Vuori, and J. Viikari, "Serum zinc and copper: associations with cholestrol and triglyceride levels in children and adolescents. Cardiovascular risk in young Finns," Journal of the American College of Nutrition, vol. 8, no. 5, pp. 400-406, 1989.
71. V. Nobili, M. Siotto, G. Bedogni et al. , "Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease," Journal of PediatricGastroenterology and Nutrition, vol. 56, no. 4, pp. 370-375, 2013.
72. A. Spruss and I. Bergheim, "Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease," Journal of Nutritional Biochemistry, vol. 20, no. 9, pp. 657-662, 2009.
73. Y. Yilmaz, "Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?" Alimentary Pharmacology and Therapeutics, vol. 36, no. 9, pp. 815-823, 2012.
74. M. Song, D. A. Schuschke, Z. Zhou et al. , "Highfructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanismfor obesity related fatty liver," Journal of Hepatology, vol. 56, no. 2, pp. 433-440, 2012.
75. P. Sharp, "The molecular basis of copper and iron interactions," Proceedings of the Nutrition Society, vol. 63, no. 4, pp. 563-569, 2004.
76. E. Aigner, I. Theurl, H. Haufe et al. , "Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease," Gastroenterology, vol. 135, no. 2, pp. 680-688, 2008.
77. S. P. Young, M. Fahmy, and S. Golding, "Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells," FEBS Letters, vol. 411, no. 1, pp. 93-96, 1997.